JG
CRL icon

Jain Global’s Charles River Laboratories CRL Stock Holding History

Jain Global’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,354
Closed -$2.03M – 1106
2025
Q2 		$2.03M Buy
13,354
+10,159
+318% +$1.35M 0.02% 500
2025
Q1 		$481K Buy
+3,195
New +$536K 0.01% 558

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jain Global's CRL Position: Q3 2025 in Review

Jain Global sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 13,354 shares — an estimated $2.03M sold.

Jain Global first reported a position in CRL in Q1 2025 and held it in 2 quarters. The position peaked at $2.03M in Q2 2025. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Jain Global reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 13,354 Charles River Laboratories shares in Q3 2025, an estimated $2.03M.
  • Jain Global first reported a position in Charles River Laboratories in Q1 2025 and held it in 2 quarters.
  • Jain Global's Charles River Laboratories position peaked at $2.03M in Q2 2025.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.